Stonebridge Financial Group (Pennsylvania)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$878K Sell
732
-292
-29% -$298K 0.07% 136
2026
Q1
$942K Buy
1,024
+49
+5% +$49.7K 0.08% 126
2025
Q4
$1.05M Sell
975
-23
-2% -$22K 0.09% 117
2025
Q3
$761K Buy
998
+20
+2% +$14.9K 0.07% 132
2025
Q2
$762K Buy
978
+7
+0.7% +$5.44K 0.07% 126
2025
Q1
$802K Sell
971
-97
-9% -$80.7K 0.09% 115
2024
Q4
$824K Buy
+1,068
New +$884K 0.09% 118

Other funds holding LLY

Stonebridge Financial Group (Pennsylvania)'s LLY Position: Q2 2026 in Review

Stonebridge Financial Group (Pennsylvania) reduced its Eli Lilly (LLY) stake by 29% in Q2 2026, selling an estimated $298K and leaving 732 shares worth $878K. The position accounts for 0.07% of the portfolio, ranked #136.

Stonebridge Financial Group (Pennsylvania) first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.05M in Q4 2025. 4,007 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stonebridge Financial Group (Pennsylvania) held 732 shares of Eli Lilly worth $878K as of Q2 2026.
  • Stonebridge Financial Group (Pennsylvania) sold 292 Eli Lilly shares in Q2 2026, an estimated $298K.
  • Eli Lilly made up 0.07% of Stonebridge Financial Group (Pennsylvania)'s portfolio in Q2 2026, its #136 holding.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Stonebridge Financial Group (Pennsylvania)'s Eli Lilly position peaked at $1.05M in Q4 2025.
  • 4,007 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2026, filed 6 Jul 2026.